Dr David Brennan, Chief Executive Officer
David Brennan has worked as a clinical scientist for 20 years specialising in Clinical Physics. During that time he has had experience in clinical research and service development. His focus has been in the field of MRI, image analysis and their clinical applications. He is a founding researcher of Aurum Biosciences having provided significant input into the development of the imaging and image analysis. During the course of Aurum’s development David has taken a keen interest in the commercial aspects of the project. He was fortunate enough to have been a student on Cambridge University’s Ignite entrepreneurial course, and MIT’s Entrepreneurship Development Program.
Dr Graeme Deuchar, R&D Director
Graeme Deuchar has over 15 years experience working as a biomedical research professional. He has an impressive track record of developing and utilising preclinical disease models combined with imaging, in projects designed to improve understanding of disease mechanism and investigate novel diagnostic and therapeutic advances in areas of cardiovascular, pulmonary and neurological medicine. Graeme is a co-founder of Aurum Biosciences Ltd where he advises on planning the current and future research and development programme required to support continued progression of the company’s key technology. Graeme also provides regulatory affairs expertise and has experience in areas related to the regulatory requirements for the development of small molecule and biopharmaceutical medicinal products.